Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

S. Wolinsky, Jerry; A. Narayana, Ponnada; O'Connor, Paul; K. Coyle, Patricia; Ford, Corey; Johnson, Kenneth; Miller, Aaron; Pardo, Lillian; Kadosh, Shaul; Ladkani, David; Trial Study Group, PROMiSe

doi:10.1002/ana.21079

Public

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Shared by NobleBlocks on Jan 1, 2007 • 12:00 AM UTC

Authors:

Jerry S. Wolinsky

Ponnada A. Narayana

Paul O'Connor

Abstract

Abstract Objective To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis. Methods A total of 943 patients with primary progressive multiple sclerosis were randomized to GA or placebo (PBO) in this 3‐year, double‐blind trial. The prima...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!